1887
Surveillance and outbreak reports Open Access
Like 0

Abstract

Invasive pneumococcal disease (IPD) is a notifiable disease in the Region of Madrid. The 23-valent pneumococcal polysaccharide vaccine (PPV23) is recommended for children and adults aged two years or over with a high risk of disease, and for all adults aged 60 and over. We describe the evolution of IPD incidence from 2008 to 2011 in people aged 60 years and over and PPV23 vaccine effectiveness (VE). VE is estimated using both the screening method and indirect cohort method. The incidence of IPD varied from 20.0 in 2008 to 15.2 per 100,000 inhabitants in 2011 (RR: 0.8; 95% CI: 0.6-0.9). Adjusted VE estimated with the screening method was 68.2% (95% CI: 56.2-76.9). VE with the Broome method was 44.5% (95% CI: 23.8-59.6) for all PPV23 serotypes, and 64.4% (95% CI: 45.2-76.8) for PPV23 serotypes not included in conjugate vaccines. VE was lower in patients aged 80 years and older (25.5%; 95% CI:-23.2 to 55.0) and those with high-risk medical conditions (31.7%; 95% CI: -2.2 to -54.4). Adjusted VE was 44.5% (95% CI: 19.4-61.8) within 5 years of vaccination and 32.5% (95% CI: -5.6 to 56.9) after 5 years. These results are compatible with current recommendations for PPV23. .

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES2014.19.40.20922
2014-10-09
2017-11-18
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES2014.19.40.20922
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/19/40/art20922-en.htm?itemId=/content/10.2807/1560-7917.ES2014.19.40.20922&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error